ABSTRACT
There are an increasing number of individuals undergoing gender-affirming hormonal treatment (GAHT) to treat gender dysphoria. Forensic alcohol calculations require knowledge of the sex of the individual but this may disadvantage trans people as research has demonstrated that there are physiological changes in individuals who are undergoing GAHT.
Using previously published studies on total body water (TBW) in cis individuals and the known changes in lean body mass and hematocrit in trans individuals, it is possible to revise the rubric for the estimation of TBW in trans individuals. We propose these revised equations are used for transgender individuals. When using these revised rubrics, we determined that for trans women the use of the cis male (sex at birth) anthropometric TBW equation only gives a small underestimation of TBW (0.9%) compared to the underestimation (−17.7%) of TBW using the cis female (affirmed gender) TBW equation. For trans men the use of gender at birth (cis female) TBW equation gives the largest disadvantage, underestimating TBW by -10.8 % compared to the affirmed gender (cis male) TBW equation that over estimates TBW by 6.6 %. For this reason, we recommend that if the sex at birth of an individual is not known or disclosed, any forensic alcohol calculations in the report are made assuming that the gender declared by the individual is their sex at birth.
HIGHLIGHTS
Large number of people taking gender-affirming hormonal treatment (GAHT) around the world
Total body water is altered in individuals taking GAHT
Forensic alcohol calculation results are affected by GAHT
Recommended that in an individual undergoing GAHT revised Watson equation used
Forensic alcohol reports state assumption that individual is cis (unless sex at birth is known)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
https://doi.org/10.1186/1743-7075-4-19 https://doi.org/10.1186/1743-7075-6-7
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
